BHS: Bausch Health Companies Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) n/a
Enterprise Value ($M) 31,976.08
Book Value ($M) 2,693.00
Book Value / Share 7.65
Price / Book 3.06
NCAV ($M) -25,497.00
NCAV / Share -72.46
Price / NCAV -0.32

Profitability (mra)
Return on Invested Capital (ROIC) -0.15
Return on Assets (ROA) -0.11
Return on Equity (ROE) -1.52

Liquidity (mrq)
Quick Ratio 0.83
Current Ratio 1.08

Balance Sheet (mrq) ($M)
Current Assets 4,275.00
Assets 32,551.00
Liabilities 29,772.00
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 0.00
Operating Income -2,384.00
Net Income -4,144.00
Earnings Per Share Basic -11.81
Earnings Per Share Basic And Diluted n/a
Earnings Per Share Diluted -11.81

Cash Flow Statement (mra) ($M)
Cash From Operations 1,501.00
Cash from Investing -196.00
Cash from Financing -196.00

Source:
Fintel.io

File Date Form Activist 13D/G Investors Ownership
(%)
Change
(%)
2017-08-09 13D Paulson & Co. Inc. 6.00 -4.47
2017-03-16 13D VA Partners I, LLC 5.20 20.03
2017-03-14 13D/A Pershing Square Capital Management, L.P. 0.00 -100.00
2017-02-07 13G/A Price T Rowe Associates Inc /md/ 0.00 -99.96
2016-06-07 13G/A Ruane, Cunniff & Goldfarb Inc 4.72 -54.45

Top 13F Investors Shares
(1000)
Change
(%)
Value
($1000)
Change
(%)

Source:
Fintel.io

Date Insider Trades Code Shares Value

Source:
Fintel.io

Similar Companies
AGN – Allergan plc ALR – Alere Inc.
BHC – BauschHealth?Companies?Inc. BMY – Bristol-Myers Squibb Co.
BXLT – Baxalta Incorporated


Financial data and stock pages provided by
Fintel.io